Weinberg FD - Search Results

1

Cyclin-dependent kinase inhibitors for the treatment of lung cancer.

Qin A, Reddy HG, Weinberg FD, Kalemkerian GP. Qin A, et al. Among authors: weinberg fd. Expert Opin Pharmacother. 2020 Jun;21(8):941-952. doi: 10.1080/14656566.2020.1738385. Epub 2020 Mar 12. Expert Opin Pharmacother. 2020. PMID: 32164461 Review.

2

Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC).

Weinberg FD, Zhao L, Chellappa N, Kalemkerian GP, Ramnath N. Weinberg FD, et al. J Thorac Dis. 2021 Feb;13(2):986-994. doi: 10.21037/jtd-20-2891. J Thorac Dis. 2021. PMID: 33717571 Free PMC article.

3

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.

Khurshid H, Ismaila N, Bian J, Dabney R, Das M, Ellis P, Feldman J, Hann C, Kulkarni S, Laskin J, Manochakian R, Mishra DR, Preeshagul I, Reddy P, Saxena A, Weinberg F, Kalemkerian GP. Khurshid H, et al. J Clin Oncol. 2023 Dec 10;41(35):5448-5472. doi: 10.1200/JCO.23.01435. Epub 2023 Oct 11. J Clin Oncol. 2023. PMID: 37820295

4

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer.

Weinberg F, Gadgeel S. Weinberg F, et al. Lung Cancer (Auckl). 2019 Jun 4;10:47-56. doi: 10.2147/LCTT.S176391. eCollection 2019. Lung Cancer (Auckl). 2019. PMID: 31239797 Free PMC article.

5

The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?

Weinberg F, Dickson RP, Nagrath D, Ramnath N. Weinberg F, et al. Cancers (Basel). 2020 Dec 22;13(1):13. doi: 10.3390/cancers13010013. Cancers (Basel). 2020. PMID: 33375062 Free PMC article. Review.

6

Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

Weinberg FD, Ramnath N. Weinberg FD, et al. Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S243-S247. doi: 10.21037/tlcr.2018.09.04. Transl Lung Cancer Res. 2018. PMID: 30393613 Free PMC article. No abstract available.

7

Reactive Oxygen Species in the Tumor Microenvironment: An Overview.

Weinberg F, Ramnath N, Nagrath D. Weinberg F, et al. Cancers (Basel). 2019 Aug 16;11(8):1191. doi: 10.3390/cancers11081191. Cancers (Basel). 2019. PMID: 31426364 Free PMC article. Review.

8

Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism.

Collin de l'Hortet A, Takeishi K, Guzman-Lepe J, Morita K, Achreja A, Popovic B, Wang Y, Handa K, Mittal A, Meurs N, Zhu Z, Weinberg F, Salomon M, Fox IJ, Deng CX, Nagrath D, Soto-Gutierrez A. Collin de l'Hortet A, et al. Cell Metab. 2019 Aug 6;30(2):385-401.e9. doi: 10.1016/j.cmet.2019.06.017. Cell Metab. 2019. PMID: 31390551 Free PMC article.

9

Corrigendum to 'Synthetic lethality: a step forward for personalized medicine in cancer' [Drug Discov. Today 25 (2020) 305-320].

Jariyal H, Weinberg F, Achreja A, Nagrath D, Srivastava A. Jariyal H, et al. Drug Discov Today. 2021 Aug;26(8):2077. doi: 10.1016/j.drudis.2020.07.016. Epub 2020 Jul 23. Drug Discov Today. 2021. PMID: 32712191 No abstract available.

10

Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer.

Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, Wuchu F, Meurs N, Mohan A, Jeon JH, Sarangi I, Jayaraman A, Owen S, Kulkarni R, Cusato M, Weinberg F, Kweon HK, Subramanian C, Wicha MS, Merajver SD, Nagrath S, Cho KR, DiFeo A, Lu X, Nagrath D. Achreja A, et al. Nat Metab. 2022 Sep;4(9):1119-1137. doi: 10.1038/s42255-022-00636-3. Epub 2022 Sep 21. Nat Metab. 2022. PMID: 36131208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page